Expert Insights

At the 2023 World Congress on Gastrointestinal Cancers, Muhammad Danyal Ahsan discusses results from a study that utilized the GENIE database to determine the potential utility of widespread functional HRD status assessment in colorectal...

At the 2023 World Congress on Gastrointestinal Cancers, Giovanni Randon, MD, presented results from a study relating clinicopathological features and immunotherapy benefit among patients with dMMR/MSI-high metastatic or unresectable gastric...

Susan M. O'Brien, MD, discusses the possible applications of pirtobrutinib, a noncovalent BTK inhibitor, for the treatment of patients with CLL.

Narendranath Epperla, MD, MS, shares findings assessing the potential significance of DTI for predicting outcomes for patients with newly diagnosed MCL.

At the 2023 EHA meeting in Frankfurt, Germany, Susan M. O'Brien, MD, provided insights into the latest frontline therapeutic options for patients with chronic lymphocytic leukemia.

At the 2023 World Congress on Gastrointestinal Cancers, Gerald Prager, MD, presents data on a trial evaluating trifluridine/tipiracil plus bevacizumab for patients with refractory metastatic colorectal cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Zev Wainberg, MD, presents data from the NAPOLI 3 study, evaluating NALIRIFOX in the first-line setting for patients with metastatic pancreatic ductal adenocarcinoma.

At the 2023 World Congress on Gastrointestinal Cancers, Akihito Kawazoe, MD, shared results from the phase 3 LEAP-017 trial, evaluating lenvatinib plus pembrolizumab among previously treated patients with metastatic colorectal cancer.

At the 2023 World Congress on Gastrointestinal Cancers, Andrea Bullock, MD, discussed the expanded phase 1 trial of bostensilimab plus balstilimab for heavily pretreated, metastatic microsatellite stable colorectal cancer.